JUBLPHARMA.NS · Jubilant Pharmova Limited
India · RS rating 40 · As of 2026-10-14
| Price | 938.90 INR |
|---|---|
| 1-day change | -0.4% |
| RS rating (overall / 1M / 3M / 12M) | 40 / 25 / 42 / 49 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 35 / 24 |
| Industry group (rank) | Pharma (32) |
| EPS growth Q/Q | -52.7% |
| Sales growth Q/Q | -2.2% |
| Distance from 52-week high | +20.5% |
| Market cap (USD) | $1.6B |